- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small Cell Lung Cancer Stage IIIA in Japan
Total 418 results
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer Stage II | Non-small Cell Lung Cancer Stage IB | Non-small Cell Lung Cancer Stage ⅢAJapan
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Tomoshi TsuchiyaCompleted
-
Hamamatsu UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaboratorsUnknownNon-small- Cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedStage IV Non-Small Cell Lung CancerSpain, United States, France, Japan
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Novartis PharmaceuticalsCompleted
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Kobe City General HospitalTerminatedAdvanced Non-small Cell Lung CancerJapan
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IVGeorgia, India, Romania, Spain, Germany, Japan, Malaysia
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
Kyowa Kirin Co., Ltd.Completed
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon Small Cell Lung CancerJapan
-
Eisai Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
Astellas Pharma Global Development, Inc.Terminated
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanUnknown
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerJapan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-Small Cell Lung CancerJapan
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Limited Stage Lung Small Cell Carcinoma | Stage I Lung Cancer AJCC v8United States, Japan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Eli Lilly and CompanyCompletedNon-small Cell Lung Cancer MetastaticJapan
-
Gunma UniversityJ~pharmaCompletedNon-Small Cell Lung Cancer | AngiogenesisJapan
-
Bristol-Myers SquibbOno Pharma USA IncCompleted
-
Eli Lilly and CompanyCompletedSquamous Non-small Cell Lung CancerJapan
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Novartis PharmaceuticalsCompletedNon-Small-Cell Lung CancerJapan
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerPhilippines, Thailand, France, Korea, Republic of, Hong Kong, United States, Turkey, Malaysia, Taiwan, Brazil, Serbia, Greece, Slovakia, Peru, South Africa, Mexico, Vietnam, Bangladesh
-
Merck Sharp & Dohme LLCCompleted